Results 51 to 60 of about 797 (106)

Availability, accessibility, and economic feasibility of radionuclide therapies in Africa: a systematic review and quantitative infrastructure analysis. [PDF]

Front Nucl Med
Ibrahim EA.
europepmc   +1 more source

Personalised Dosimetry in Nuclear Medicine: Bridging Physics, Biology and AI for Next Generation Radiopharmaceutical Therapy. [PDF]

Nucl Med Mol Imaging
Shanmugiah J, Kim JS.
europepmc   +1 more source

Population pharmacokinetic modeling in radiopharmaceutical therapy: a review. [PDF]

Front Nucl Med
Hardiansyah D, Patrianesha BB, Glatting G.   +2 more
europepmc   +1 more source

In Vivo Studies of [¹⁶¹Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2-Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth Suppression. [PDF]

J Nucl Med
Cold S, Sadasivam P, Wessel MM, Ischyropoulou M, Fonslet J, Engel TB, Nielsen CH, Kjaer A, Kristensen LK.   +8 more
europepmc   +1 more source

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology). [PDF]

Pharmaceutics
Salgueiro MJ, Zubillaga M.
europepmc   +1 more source

Recent trends in the utilization of molecular breast imaging in the United States. [PDF]

Clin Imaging
Dave R, Gu L, Garrett HV, Bennett D, Stwalley D, Singer S, Chiu S, Lee MV.   +7 more
europepmc   +1 more source

Occupational radiation safety and sustainable workforce management in PET/CT practice: a pilot study of healthcare professionals in a newly established cyclotron-based nuclear medicine center. [PDF]

Front Public Health
Marshall SK, Mewes K, Noomad N, Durawee W, Hayeeabdunromae A.   +4 more
europepmc   +1 more source

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Zhang S, Liu C, Lu Q, Liu W, Wu J, Liu J, Tong L, Zhao K, Hu Q, Chen X, Li L, Song X, Wang F, Dai D, Wang R, Hu K.   +15 more
europepmc   +1 more source

Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. [PDF]

Radiat Prot Dosimetry
Rassol N, Ytterbrink C, Pettersson D, Al-Awar A, Bakr H, Gram M, Spetz J, Forssell-Aronsson E.   +7 more
europepmc   +1 more source

Copper-mediated radiochemistry: historical impact, current trends, and future possibilities. [PDF]

Npj Imaging
Bowden GD, Müller M, Herth MM, Sanford MS, Scott PJH.   +4 more
europepmc   +1 more source